🔴 Femasys is trading 5.9% down in pre-market with no clear company-specific catalyst identified

Femasys is trading at $2.43, down 5.87%, with no clear company-specific announcement surfaced for September 24, 2026.

• Higher Treasury yields and renewed Fed-tightening concerns are pressuring broader markets.
• Biotech is outperforming overall markets, reducing support for a sector-wide explanation.
• Recent Femasys coverage highlighted prior fertility-product expansion, not a fresh catalyst.